Smith Anglin Financial’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72K | Hold |
12,000
| – | – | ﹤0.01% | 209 |
|
|
2025
Q1 | $5.05K | Hold |
12,000
| – | – | ﹤0.01% | 213 |
|
|
2024
Q4 | $8.42K | Hold |
12,000
| – | – | ﹤0.01% | 213 |
|
|
2024
Q3 | $5.62K | Hold |
12,000
| – | – | ﹤0.01% | 207 |
|
|
2024
Q2 | $19.9K | Hold |
12,000
| – | – | ﹤0.01% | 195 |
|
|
2024
Q1 | $21.8K | Hold |
12,000
| – | – | ﹤0.01% | 198 |
|
|
2023
Q4 | $22.2K | Buy |
+12,000
| New | +$22.2K | ﹤0.01% | 182 |
|